Effects of n-acetylcysteine on ischemic preconditioning. Study in isolated rat hearts;Efeitos da N-acetilcisteína no precondicionamento isquêmico: Estudo em corações isolados de ratos

Brazilian Journal of Cardiovascular Surgery

Volumn 24, Issue 1, 2009, Pages 23-30

  de Oliveira, Denoel Marcelino ^a   Gomes, Eros Silva ^a   Mussivand, Tofy ^a   Fiorelli, Alfredo Inácio ^a   Gomes, Otoni Moreira ^a  

^a ServCor   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; SCAVENGER;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL MODEL; ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART CONTRACTION; HEART INFARCTION PREVENTION; HEART RATE; METHODOLOGY; RAT; TIME; WISTAR RAT;

ACETYLCYSTEINE; ANALYSIS OF VARIANCE; ANIMALS; CORONARY CIRCULATION; FREE RADICAL SCAVENGERS; HEART RATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MODELS, ANIMAL; MYOCARDIAL CONTRACTION; RATS; RATS, WISTAR; TIME FACTORS;

EID: 70350641205     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/s0102-76382009000100006     Document Type: Article

References (25)

1. Ko W, Krieger KH, Isom OW. A historical perspective to current review of myocardial protection in cardiac operation. Surg Gynecol Obstet. 1993;177(5):529-43.
2. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124-36.
3. Vaage J, Valen G. Preconditioning and cardiac surgery. Ann Thorac Surg. 2003;75(2):S709-14.
4. Vinten-Johansen J, Zhao ZQ, Corvera JS, Morris CD, Budde JM, Thourani VH, et al. Adenosine in myocardial protection in on-pump and off-pump cardiac surgery. Ann Thorac Surg. 2003;75(2):S691-9.
5. Julier K, Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology. 2003;98(6):1315-27.
6. Morris SD, Yellon DM. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart. J Am Coll Cardiol. 1997;29(7):1599-606.
7. Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, et al. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res. 2000;86(2):144-51.
8. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res. 1997; 81(6):1072-82.
9. Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS, et al. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res. 2000;87(6):460-6.
10. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res. 2001;88(8):802-9.
11. Sochman J. Regional ischaemic and reperfusion injury, free oxygen radicals and the possible role of N-acetylcysteine in acute myocardial infarction. Cor Vasa 1994;36(6):269-79.
12. Chen W, Gabel S, Steenbergen C, Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res. 1995; 77(2):424-9.
13. Oliveira DM, Abrantes R, Gomes ES, Gomes OM. Efeitos da N-acetilcisteína sobre o pré-condicionamento isquêmico do miocárdio: estudo comparativo da frequência cardíaca, fluxo coronariano e contratilidade miocárdica em corações isolados de ratos. Revista da SOCERJ. 2006;19(supl. A):7.
14. Jeroudi MO, Hartley CJ, Bolli R. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol. 1994;73(6):2B-7B.
15. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol. 1997;29(1):207-16.
16. Hsu BG, Yang FL, Lee RP, Peng TC, Harn HJ, Chen HI. N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats. J Biomed Sci. 2004;11(2):152-62.
17. Delgado JL, Landeras J, Carbonell LF, Parilla JJ, Abad L, Quesada T, et al. Effect of N-acetylcysteine on vascular endothelium function in aorta from oophorectomized rats. Gen Pharmacol. 1999;32(1):23-7.
18. Singh RJ, Hogg N, Joseph J, Kalyanaraman B. Mechanism of nitric oxide release from S-nitrosothiols. J Biol Chem. 1996;271(31):18596-603.
19. Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol. 2000;32(7):1159-67.
20. Bell RM, Yellon DM. The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice. Cardiovasc Res. 2001;52(2):274-80.
21. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 1993;72(6):1293-9.
22. Hoshida S, Kuzuya T, Fuji H, Yamashita N, Oe H, Hori M, et al. Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol. 1993;264(1 Pt 2): H33-9.
23. Baxter GF, Yellon DM. ATP-sensitive K+ channels mediate the delayed cardioprotective effect of adenosine A1 receptor activation. J Mol Cell Cardiol. 1999;31(5):981-9.
24. Burckhartt B, Yang XM, Tsuchida A, Mullane KM, Downey JM, Cohen MV. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits. Cardiovasc Res. 1995;29(5):653-7.
25. Takano H, Tang XL, Qiu Y, Guo Y, French BA, Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res. 1998;83(1):73-84.